Conduit Pharmaceuticals I...

1.86
-0.99 (-34.74%)
At close: Feb 10, 2025, 3:59 PM
1.85
-0.59%
After-hours Feb 10, 2025, 07:59 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY24 FY23 FY22 FY21
PE Ratio 1.41 -56.96K -3.63K -4.70K
PS Ratio 0.11 n/a n/a n/a
PB Ratio n/a -66.68K -1.76K -2.89K
P/FCF Ratio 1.25 -3.94K -7.82K -7.99K
P/OCF Ratio 0.81 -3.94K -7.82K -7.99K
OCF/S Ratio 0.14 n/a n/a n/a
Debt / Equity Ratio n/a -2.16 -0.2 -0.13
Quick Ratio n/a 3.18 0.16 0.05
Current Ratio n/a 3.18 0.16 0.05
Asset Turnover n/a n/a n/a n/a
Interest Coverage -6.96 -26.36 n/a n/a
Return on Equity (ROE) n/a 1.17 0.49 0.62
Return on Assets (ROA) n/a -0.07 -977.4 -17.16
Return on Capital (ROIC) n/a -1.03 0.79 1.57
Dividend Yield 0.03 n/a n/a n/a
Payout Ratio 0.04 n/a n/a n/a
Gross Profit Margin 37.47% n/a n/a n/a
Net Profit Margin 8.06% n/a n/a n/a
Pretax Profit Margin 9.26% n/a n/a n/a
Operating Profit Margin 10.83% n/a n/a n/a
FCF Margin 9.06% n/a n/a n/a
EBITDA Margin 10.83% n/a n/a n/a